Sudeep Pharma Gains Gujarat FDA Approval for Nandesari Facility

Sudeep Pharma Limited has received approval from the Gujarat Food and Drug Control Administration to commence manufacturing operations at its new pharmaceutical greenfield facility at 179 Nandesari, Gujarat, according to Themachinemaker.

The publisher reported that the approval covers the start of operations at the new facility. It also confirms that the site’s manufacturing systems, quality controls and compliance framework meet requirements for beginning operations.

Approval supports manufacturing start

Themachinemaker said Sudeep Pharma received approval for its new Nandesari facility from the Gujarat Food and Drug Control Administration. The event enables the company to commence manufacturing operations at the greenfield pharmaceutical site.

According to the publisher, the regulator’s approval confirms readiness across three areas: manufacturing systems, quality controls and the compliance framework. These were identified as meeting the requirements for starting operations.

Nandesari facility details

The facility is located at 179 Nandesari, Gujarat, Themachinemaker reported. The outlet identified the company as Sudeep Pharma Limited, with NSE: SUDEEPPHRM and BSE: 544619.

For medical and pharmaceutical sales professionals, the reported approval is a company manufacturing and compliance development. Discussions of the announcement can remain centered on the regulator’s authorization to begin operations and the publisher’s description of the facility’s systems, controls and compliance framework.

Key points reported by Themachinemaker

• Sudeep Pharma Limited received approval from the Gujarat Food and Drug Control Administration.
• The approval applies to a new pharmaceutical greenfield facility at 179 Nandesari, Gujarat.
• The company can commence manufacturing operations at the facility.
• The approval confirms that manufacturing systems, quality controls and the compliance framework meet requirements for starting operations.

Themachinemaker characterized the approval as a milestone for the new Nandesari manufacturing facility and its commencement of operations.